PubMed HealthSearch

PubMed · 6867168

Levator muscle reconstruction: does it make a difference?

Abstract

Eighty-five children from 6 to 8 months of age underwent palatal reconstruction between 1972 and 1978. Forty had palatal repair without levator reconstruction, and 45 had an intravelar veloplasty. Speech assessment was performed at 2 years after surgery. Any nasal escape or hypernasality, whether consistent or not, was included as abnormal speech. The data revealed that 70 percent (28 of 40) had abnormal speech when no muscle reconstruction was performed compared with 63 percent (24 of 45) after having had an intravelar veloplasty. We conclude that the added operative dissection adds no morbidity to the procedure and that the improved speech results probably justify performing an intravelar veloplasty when doing a palatal repair.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A S Brown, M A Cohen, P Randall. 1983. Levator muscle reconstruction: does it make a difference?. https://doi.org/10.1097/00006534-198307000-00001

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Proteomic analysis illustrates the potential involvement of dysregulated ribosome-related pathways and disrupted metabolism during retinoic acid-induced cleft palate development.

Recent studies have unveiled disrupted metabolism in the progression of cleft palate (CP), a congenital anomaly characterized by defective fusion of facial structures. Nonetheless, the precise composition of this disrupted metabolism remains elusive, prompting us to identify these components and elucidate primary metabolic irregularities contributing to CP pathogenesis. We established a murine CP model by retinoic acid (RA) treatment and analyzed control and RA-treated embryonic palatal tissues by LC-MS-based proteomic approach. We identified 220 significantly upregulated and 224 significantly downregulated proteins. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed that these differentially expressed proteins (DEPs) were involved in translation, ribosome assembly, mitochondrial function, mRNA binding, as well as key metabolic pathways like oxidative phosphorylation (OXPHOS), glycolysis/gluconeogenesis, and amino acid biosynthesis. These findings suggest that dysregulated ribosome-related pathways and disrupted metabolism play a critical role in CP development. Protein-protein interaction analysis using the STRING database revealed a tightly connected network of DEPs. Furthermore, we identified the top 10 hub proteins in CP using the Cytohubba plugin in Cytoscape. These hub proteins, including RPL8, RPS11, ALB, PA2G4, RPL23, RPS6, CCT7, EGFR, HSPD1, and RPS28, are potentially key regulators of CP pathogenesis. In conclusion, our comprehensive proteomic analysis provides insights into the molecular alterations associated with RA-induced CP in Kun Ming mice. These findings suggest potential therapeutic targets and pathways to understand and prevent congenital craniofacial anomalies.

Cleft Palate